Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1995 1
1997 1
1998 3
2002 1
2005 1
2006 1
2008 1
2015 1
2016 1
2018 1
2019 2
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Anti-D isoimmunization affecting pregnancy"
Page 1
RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates.
Legler TJ. Legler TJ. Transfus Apher Sci. 2020 Oct;59(5):102950. doi: 10.1016/j.transci.2020.102950. Epub 2020 Sep 25. Transfus Apher Sci. 2020. PMID: 33004277 Review.
Rhesus D (RhD) negative pregnant women carrying an RhD positive fetus are at risk of developing anti-D during or after pregnancy. Anti-d-immunoglobulin (RhIg), which is mainly produced from special plasma donated in a few countries for the whole …
Rhesus D (RhD) negative pregnant women carrying an RhD positive fetus are at risk of developing anti-D during or after preg …
Management of neonatal Rh disease.
Peterec SM. Peterec SM. Clin Perinatol. 1995 Sep;22(3):561-92. Clin Perinatol. 1995. PMID: 8521682 Free article. Review.
Dramatic improvements have been made in the management of Rh disease. Anti-D immune globulin has reduced the incidence of Rh sensitization. Intrauterine transfusions have become routine to treat fetal anemia. Once an affected infant is born, several recent im …
Dramatic improvements have been made in the management of Rh disease. Anti-D immune globulin has reduced the incidence of Rh s …
Management of rhesus alloimmunization in pregnancy.
Moise KJ Jr. Moise KJ Jr. Obstet Gynecol. 2008 Jul;112(1):164-76. doi: 10.1097/AOG.0b013e31817d453c. Obstet Gynecol. 2008. PMID: 18591322 Review.
The rarity of this condition warrants consideration of consultation with or referral to a maternal-fetal medicine specialist with experience in the monitoring and treatment of patients with red cell alloimmunization in pregnancy. Evaluation for the presence of maternal …
The rarity of this condition warrants consideration of consultation with or referral to a maternal-fetal medicine specialist with experience …
Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
Gudlaugsson B, Hjartardottir H, Svansdottir G, Gudmundsdottir G, Kjartansson S, Jonsson T, Gudmundsson S, Halldorsdottir AM. Gudlaugsson B, et al. Transfusion. 2020 Jan;60(1):175-183. doi: 10.1111/trf.15635. Epub 2019 Dec 18. Transfusion. 2020. PMID: 31850521 Clinical Trial.
The aim of this study was to investigate the incidence, causes, and consequences of anti-D alloimmunizations in pregnancy in Iceland, prior to implementation of targeted routine antenatal anti-D prophylaxis (RAADP) in 2018. ...Higher anti …
The aim of this study was to investigate the incidence, causes, and consequences of anti-D alloimmunizations in pregnancy …
Management of rhesus alloimmunization in pregnancy.
Moise KJ Jr. Moise KJ Jr. Obstet Gynecol. 2002 Sep;100(3):600-11. doi: 10.1016/s0029-7844(02)02180-4. Obstet Gynecol. 2002. PMID: 12220785 Review.
Once sensitization occurs, rhesus immune globulin is no longer effective. Evaluation for the presence of maternal anti-D antibody should be undertaken at the first prenatal visit. First-time sensitized pregnancies are followed with serial maternal titers and, …
Once sensitization occurs, rhesus immune globulin is no longer effective. Evaluation for the presence of maternal anti-D antib …
The evaluation of maternal anti-D concentrations during pregnancy.
Filbey D, Berseus O, Sandström B, Wesström G. Filbey D, et al. Early Hum Dev. 1987 Jan;15(1):1-9. doi: 10.1016/0378-3782(87)90095-8. Early Hum Dev. 1987. PMID: 3102209
Anti-D quantitation by the AutoAnalyzer technique has been shown to be a helpful aid in assessing the severity of D alloimmunization during pregnancy. ...A titre of 32 was found to be a good discriminative level to separate the mildly affected from the …
Anti-D quantitation by the AutoAnalyzer technique has been shown to be a helpful aid in assessing the severity of D alloimmuni …
Rh immune globulin: an interfering substance in compatibility testing.
Casina TS, Sandler SG, Autenrieth SM. Casina TS, et al. Immunohematology. 2019 Jun;35(2):51-60. Immunohematology. 2019. PMID: 31246488
Because an antenatal injection of RhIG is indicated for pregnant Rh-negative women, anti-D is detected frequently by today's highly sensitive antibody screen methods when the mother's plasma is tested subsequently at delivery. Ascertaining the source of anti- …
Because an antenatal injection of RhIG is indicated for pregnant Rh-negative women, anti-D is detected frequently by today's h …
High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.
Saramago P, Yang H, Llewellyn A, Palmer S, Simmonds M, Griffin S. Saramago P, et al. BJOG. 2018 Oct;125(11):1414-1422. doi: 10.1111/1471-0528.15152. Epub 2018 Mar 15. BJOG. 2018. PMID: 29415334 Free article.
OBJECTIVE: To evaluate the cost-effectiveness of high-throughput, non-invasive prenatal testing (HT-NIPT) for fetal Rhesus D (RhD) genotype to guide antenatal prophylaxis with anti-D immunoglobulin compared with routine antenatal anti-D immunoglobulin …
OBJECTIVE: To evaluate the cost-effectiveness of high-throughput, non-invasive prenatal testing (HT-NIPT) for fetal Rhesus D (RhD) genotype …
Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
Gottvall T, Hildén JO. Gottvall T, et al. Acta Obstet Gynecol Scand. 1997 Sep;76(8):733-8. doi: 10.3109/00016349709024338. Acta Obstet Gynecol Scand. 1997. PMID: 9348249 Free article.
OBJECTIVES: To define a simple, safe and reliable program for the monitoring of anti-D alloimmunized pregnancies by analysis of the covariation between antenatal values of the titer and the concentration of anti-D antibodies in maternal serum, t …
OBJECTIVES: To define a simple, safe and reliable program for the monitoring of anti-D alloimmunized pregnancies by ana …
Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis.
Szkotak AJ, Lunty B, Nahirniak S, Clarke G. Szkotak AJ, et al. Vox Sang. 2016 Jan;110(1):51-9. doi: 10.1111/vox.12302. Epub 2015 May 29. Vox Sang. 2016. PMID: 26031621
BACKGROUND AND OBJECTIVES: Determining whether anti-D represents active or passive alloimmunization after RhIg administration is challenging. The objectives were to use antibody reaction strength to differentiate patients who may have become RhD alloimmunized during …
BACKGROUND AND OBJECTIVES: Determining whether anti-D represents active or passive alloimmunization after RhIg administration …
17 results